|
US20030157036A1
(en)
*
|
2002-02-20 |
2003-08-21 |
Osborne David W. |
Topical dapsone for the treatment of acne
|
|
US5863560A
(en)
*
|
1996-09-11 |
1999-01-26 |
Virotex Corporation |
Compositions and methods for topical application of therapeutic agents
|
|
US6787157B1
(en)
*
|
1998-03-10 |
2004-09-07 |
Abbott Laboratories |
Multiphase active ingredient-containing formulations
|
|
US6294188B1
(en)
|
1998-07-09 |
2001-09-25 |
Aviana Biopharm Inc. |
Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women
|
|
RU2148396C1
(ru)
*
|
1998-08-25 |
2000-05-10 |
Пермское научно-производственное объединение "Биомед" |
Способ определения активного вещества в дифильных мазевых основах
|
|
ATE326205T1
(de)
*
|
2000-01-31 |
2006-06-15 |
Engelhard Corp |
Tensidfreietopische zusammensetzungen und verfahren zur schnelle herstellung davon
|
|
US20040002482A1
(en)
*
|
2000-08-30 |
2004-01-01 |
Dudley Robert E. |
Androgen pharmaceutical composition and method for treating depression
|
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
|
US20020193321A1
(en)
*
|
2000-12-12 |
2002-12-19 |
Mohan Vishnupad |
Dual dispenser for aesthitically acceptable delivery of anhydrous skin treatment compositions
|
|
US6998421B2
(en)
|
2001-06-07 |
2006-02-14 |
Biozone Laboratories, Inc. |
Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase - 2
|
|
US6495596B1
(en)
|
2001-03-23 |
2002-12-17 |
Biozibe Laboratories, Inc. |
Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase-2
|
|
US6475526B1
(en)
|
2001-06-05 |
2002-11-05 |
Jeffrey B. Smith |
Zinc containing compositions for anti-viral use
|
|
US20040072810A1
(en)
|
2001-11-07 |
2004-04-15 |
Besins International Belgique |
Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
|
|
US20030144362A1
(en)
*
|
2002-01-28 |
2003-07-31 |
Utterberg David S. |
High viscosity antibacterials for cannulae
|
|
US20050042240A1
(en)
*
|
2002-01-28 |
2005-02-24 |
Utterberg David S. |
High viscosity antibacterials
|
|
WO2003092704A1
(fr)
*
|
2002-04-30 |
2003-11-13 |
Mochida Pharmaceutical Co., Ltd. |
Preparation externe de vidarabine a propriete systemique amelioree
|
|
US20040086469A1
(en)
*
|
2002-10-30 |
2004-05-06 |
Osborne David W. |
Protectant for UV-induced skin damage
|
|
US6855341B2
(en)
*
|
2002-11-04 |
2005-02-15 |
Jeffrey B. Smith |
Anti-viral compositions and methods of making and using the anti-viral compositions
|
|
US20080274209A1
(en)
*
|
2002-11-04 |
2008-11-06 |
Integritas Pharma, Inc. |
Methods of treating inflammation
|
|
JP4591746B2
(ja)
*
|
2002-12-03 |
2010-12-01 |
大正製薬株式会社 |
難溶性抗ウイルス成分含有水溶性外用剤組成物
|
|
WO2004105662A1
(en)
*
|
2003-05-23 |
2004-12-09 |
Program For Appropriate Technology In Health |
Microbicidal compositions and methods of use
|
|
US7186416B2
(en)
*
|
2003-05-28 |
2007-03-06 |
Stiefel Laboratories, Inc. |
Foamable pharmaceutical compositions and methods for treating a disorder
|
|
US20060229258A1
(en)
*
|
2003-07-30 |
2006-10-12 |
Daniela Serikaku |
Steroidal compositions containing hydroxycarboxylic acids and methods of using the same
|
|
US20060204526A1
(en)
*
|
2003-08-13 |
2006-09-14 |
Lathrop Robert W |
Emulsive composition containing Dapsone
|
|
AU2004264964A1
(en)
*
|
2003-08-13 |
2005-02-24 |
Qlt Usa, Inc. |
Emulsive composition containing dapsone
|
|
US20050191338A1
(en)
*
|
2004-01-30 |
2005-09-01 |
Lifeng Kang |
Transdermal drug delivery composition comprising a small molecule gel and process for the preparation thereof
|
|
US7767215B2
(en)
*
|
2004-06-29 |
2010-08-03 |
Mcka Llc |
Topical compositions for anti-aging and methods of using same
|
|
US20060024372A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Utterberg David S |
High viscosity antibacterials
|
|
WO2006037047A2
(en)
*
|
2004-09-27 |
2006-04-06 |
Bridge Pharma, Inc. |
The r-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
|
|
US7718674B2
(en)
*
|
2004-09-27 |
2010-05-18 |
Bridge Pharma, Inc. |
Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
|
|
EP1814574A4
(en)
|
2004-10-27 |
2009-08-05 |
Univ Denver |
ANALOGUE OF ADRENOCORTICOTROPEN HORMON AND CORRESPONDING METHODS
|
|
US20070088012A1
(en)
*
|
2005-04-08 |
2007-04-19 |
Woun Seo |
Method of treating or preventing type-2 diabetes
|
|
JP2008536937A
(ja)
*
|
2005-04-20 |
2008-09-11 |
ザイロス コーポレイション |
経皮薬物送達系に用いる微生物セルロース材料、製造および使用方法
|
|
US20060271262A1
(en)
*
|
2005-05-24 |
2006-11-30 |
Mclain Harry P Iii |
Wireless agricultural network
|
|
WO2008018854A2
(en)
*
|
2005-06-06 |
2008-02-14 |
The Rockefeller University |
Bactiophage lysins for bacillus anthracis
|
|
US20100154146A1
(en)
|
2008-07-02 |
2010-06-24 |
S.C. Johnson & Son, Inc. |
Carpet decor and setting solution compositions
|
|
US8846154B2
(en)
|
2005-06-07 |
2014-09-30 |
S.C. Johnson & Son, Inc. |
Carpet décor and setting solution compositions
|
|
US7582291B2
(en)
*
|
2005-06-30 |
2009-09-01 |
The Rockefeller University |
Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria
|
|
ITMI20051417A1
(it)
*
|
2005-07-22 |
2007-01-23 |
Mipharm S P A |
Formulazione topica in forma di gel contenente come ingredienti attivi ciclovit e lidocaina
|
|
WO2007016450A2
(en)
*
|
2005-07-29 |
2007-02-08 |
Beth Israel Deaconess Medical Center |
Methods for treating or preventing reactivation of a latent herpesvirus infection
|
|
ES2357626T3
(es)
*
|
2005-08-24 |
2011-04-28 |
The Rockefeller University |
Lisinas mutantes de ply-gbs.
|
|
US20070071705A1
(en)
*
|
2005-09-29 |
2007-03-29 |
De Oliveira Monica A M |
Topical anti-microbial compositions
|
|
SI1937276T1
(sl)
|
2005-10-12 |
2013-04-30 |
Unimed Pharmaceuticals, Llc C/O Abbott Laboratoires 100 Abbott Park Road |
Izboljšani testosteronski gel in postopek uporabe
|
|
JP2007320886A
(ja)
*
|
2006-05-31 |
2007-12-13 |
Isp Japan Kk |
含水ゲル状シート剤及びその製造方法
|
|
WO2008011161A2
(en)
*
|
2006-07-21 |
2008-01-24 |
Bridge Pharma, Inc. |
Dermal anesthetic compounds
|
|
BRPI0822264A2
(pt)
|
2008-02-27 |
2014-09-30 |
Allergan Inc |
Dapsona para tratar rosácea
|
|
US20100029781A1
(en)
*
|
2008-06-04 |
2010-02-04 |
Morris Jerome A |
Methods for preparation of anti-acne formulation and compositions prepared thereby
|
|
JP5732397B2
(ja)
|
2008-10-10 |
2015-06-10 |
ルソメディカメンタ, エス.エー.Lusomedicamenta, S.A. |
抗菌性ファージペプチド及びその使用法
|
|
EP3115054B1
(en)
|
2009-02-06 |
2019-11-20 |
Technophage, Investigação E Desenvolvimento Em Biotecnologia, SA |
Antibacterial phage, phage peptides and methods of use thereof
|
|
US20110117182A1
(en)
*
|
2009-07-30 |
2011-05-19 |
Allergan, Inc. |
Combination of dapsone with other anti-acne agents
|
|
US8999302B1
(en)
|
2009-10-22 |
2015-04-07 |
Aplicare, Inc. |
Skin dye protectant formulations
|
|
PT104837A
(pt)
|
2009-11-24 |
2011-05-24 |
Technophage Investiga O E Desenvolvimento Em Biotecnologia S A |
P?ptidos de fagos enteroc?cicos e m?todos para a sua utiliza??o
|
|
US10045996B2
(en)
|
2010-03-17 |
2018-08-14 |
Novaliq Gmbh |
Pharmaceutical composition for treatment of increased intraocular pressure
|
|
EP3443970B1
(en)
|
2010-09-17 |
2020-09-09 |
Tecnifar-Indústria Técnica Farmacêutica, S.A. |
Antibacterial phage, phage peptides and methods of use thereof
|
|
EP2444063A1
(en)
|
2010-10-20 |
2012-04-25 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the delivery of active ingredients
|
|
PH12013500738A1
(en)
|
2010-10-21 |
2016-08-05 |
Galderma Sa |
Brimonidine gel compositions and methods of use
|
|
US9034322B2
(en)
|
2011-04-21 |
2015-05-19 |
The Rockefeller University |
Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
|
|
EP2714010B1
(en)
*
|
2011-05-25 |
2017-03-01 |
Novaliq GmbH |
Topical pharmaceutical composition based on semifluorinated alkanes
|
|
AU2012275714A1
(en)
*
|
2011-06-30 |
2014-01-30 |
Allergan, Inc. |
Retinoid topical compositions and methods for treating skin conditions
|
|
RU2654596C2
(ru)
|
2012-03-19 |
2018-05-21 |
Текнифар-Индустриа Текника Фармасеутика С.А. |
Композиции коктейля, содержащие антибактериальные фаги, и способы их применения
|
|
CN104619314B
(zh)
|
2012-09-12 |
2017-09-22 |
诺瓦利克有限责任公司 |
包含半氟化烷烃的混合物的组合物
|
|
BR112015005008B1
(pt)
|
2012-09-12 |
2022-04-19 |
Novaliq Gmbh |
Composições de alcano semifluorado
|
|
PL2922528T3
(pl)
|
2012-11-20 |
2017-12-29 |
Allergan, Inc. |
Miejscowe kompozycje dapsonu i dapsonu/adapalenu i sposoby ich stosowania
|
|
US9012402B1
(en)
|
2014-06-11 |
2015-04-21 |
James Blanchard |
Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
|
|
CA2956823A1
(en)
|
2014-07-31 |
2016-02-04 |
Allergan, Inc. |
Comparative efficacy and tolerability of dapsone 5% in adult versus adolescent females with acne vulgaris
|
|
CN113662929A
(zh)
|
2015-09-30 |
2021-11-19 |
诺瓦利克有限责任公司 |
用于眼部给药的半氟化化合物
|
|
CN108348777B
(zh)
|
2015-09-30 |
2020-04-28 |
诺瓦利克有限责任公司 |
半氟化化合物和其组合物
|
|
JP6951332B2
(ja)
*
|
2015-11-04 |
2021-10-20 |
アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ |
局所用ダプソン組成物を使用して尋常性座瘡を処置する方法
|
|
USRE50060E1
(en)
|
2016-06-23 |
2024-07-30 |
Novaliq Gmbh |
Topical administration method
|
|
ES2969758T3
(es)
|
2016-09-22 |
2024-05-22 |
Novaliq Gmbh |
Composiciones farmacéuticas para usar en la terapia de la blefaritis
|
|
KR20190057338A
(ko)
|
2016-09-23 |
2019-05-28 |
노바리크 게엠베하 |
시클로스포린을 포함하는 안과 조성물
|
|
ES2819005T3
(es)
|
2016-12-23 |
2021-04-14 |
Novaliq Gmbh |
Composición oftálmica para el tratamiento de la enfermedad del ojo seco
|
|
EP3612228B1
(en)
|
2017-04-21 |
2023-08-23 |
Dermaliq Therapeutics, Inc. |
Iodine compositions
|
|
US11278503B2
(en)
|
2017-05-12 |
2022-03-22 |
Novaliq Gmbh |
Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
|
|
US12011437B1
(en)
|
2017-06-07 |
2024-06-18 |
Arcutis Biotherapeutics, Inc. |
Roflumilast formulations with an improved pharmacokinetic profile
|
|
US9895359B1
(en)
|
2017-06-07 |
2018-02-20 |
Arcutis, Inc. |
Inhibition of crystal growth of roflumilast
|
|
US11129818B2
(en)
|
2017-06-07 |
2021-09-28 |
Arcutis Biotherapeutics, Inc. |
Topical roflumilast formulation having improved delivery and plasma half life
|
|
US12042487B2
(en)
|
2018-11-16 |
2024-07-23 |
Arcutis Biotherapeutics, Inc. |
Method for reducing side effects from administration of phosphodiesterase-4 inhibitors
|
|
US20200155524A1
(en)
|
2018-11-16 |
2020-05-21 |
Arcutis, Inc. |
Method for reducing side effects from administration of phosphodiesterase-4 inhibitors
|
|
US20210161870A1
(en)
|
2017-06-07 |
2021-06-03 |
Arcutis Biotherapeutics, Inc. |
Roflumilast formulations with an improved pharmacokinetic profile
|
|
US10821075B1
(en)
|
2017-07-12 |
2020-11-03 |
James Blanchard |
Compositions for topical application of a medicaments onto a mammalian body surface
|
|
MX2020003534A
(es)
|
2017-09-27 |
2020-07-29 |
Novaliq Gmbh |
Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares.
|
|
CN111182893A
(zh)
|
2017-10-04 |
2020-05-19 |
诺瓦利克有限责任公司 |
包含f6h8的眼用组合物
|
|
WO2019126670A1
(en)
|
2017-12-22 |
2019-06-27 |
The Rockefeller University |
Recombinant pseudomonas aeruginosa lysins
|
|
AU2019228119A1
(en)
|
2018-03-02 |
2020-09-10 |
Novaliq Gmbh |
Pharmaceutical compositions comprising nebivolol
|
|
IL276888B2
(en)
|
2018-03-28 |
2024-12-01 |
Novaliq Gmbh |
Pharmaceutical composition comprising timolol
|
|
EP3784246A1
(en)
|
2018-04-27 |
2021-03-03 |
Novaliq GmbH |
Ophthalmic compositions comprising tafluprost for the treatment of glaucoma
|
|
CA3102689C
(en)
|
2018-06-04 |
2023-08-29 |
Arcutis, Inc. |
Method and formulation for improving roflumilast skin penetration lag time
|
|
ES2950878T3
(es)
|
2018-09-27 |
2023-10-16 |
Dermaliq Therapeutics Inc |
Formulación de protección solar de uso tópico
|
|
EP3856124A1
(en)
|
2018-09-27 |
2021-08-04 |
Novaliq GmbH |
Lipid barrier repair
|
|
CN112823020A
(zh)
|
2018-10-12 |
2021-05-18 |
诺瓦利克有限责任公司 |
用于治疗干眼病的眼用组合物
|
|
EP3923907B1
(en)
|
2019-02-13 |
2024-09-25 |
Novaliq GmbH |
Compositions and methods for the treatment of ocular neovascularization
|
|
EP3937905A4
(en)
|
2019-03-14 |
2022-12-28 |
Crescita Therapeutics Inc. |
RINSING COMPOSITIONS AND THEIR USES FOR THE ADMINISTRATION OF ACTIVE AGENTS
|
|
US12098372B2
(en)
|
2019-12-30 |
2024-09-24 |
Eligo Bioscience |
Microbiome modulation of a host by delivery of DNA payloads with minimized spread
|
|
US11746352B2
(en)
|
2019-12-30 |
2023-09-05 |
Eligo Bioscience |
Microbiome modulation of a host by delivery of DNA payloads with minimized spread
|
|
CN115551478A
(zh)
|
2020-01-31 |
2022-12-30 |
阿尔库缇斯生物疗法股份有限公司 |
具有改善递送和血浆半衰期的罗氟司特局部制剂
|
|
WO2021204967A1
(en)
|
2020-04-08 |
2021-10-14 |
Eligo Bioscience |
Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders
|
|
US11617773B2
(en)
|
2020-04-08 |
2023-04-04 |
Eligo Bioscience |
Elimination of colonic bacterial driving lethal inflammatory cardiomyopathy
|
|
DE21179356T1
(de)
|
2020-06-12 |
2022-02-17 |
Eligo Bioscience |
Spezifische entkolonisierung von antibiotikaresistenten bakterien für prophylaktische zwecke
|
|
WO2022003209A1
(en)
|
2020-07-03 |
2022-01-06 |
Eligo Bioscience |
Method of containment of nucleic acid vectors introduced in a microbiome population
|
|
JP2023541257A
(ja)
|
2020-09-11 |
2023-09-29 |
ピナクル バイオロジクス，インコーポレイテッド |
光線力学療法組成物及びその使用方法
|
|
EP4458414A3
(en)
|
2020-12-04 |
2025-01-01 |
Arcutis Biotherapeutics, Inc. |
Topical roflumilast formulation having antifungal properties
|
|
WO2022144382A1
(en)
|
2020-12-30 |
2022-07-07 |
Eligo Bioscience |
Chimeric receptor binding proteins resistant to proteolytic degradation
|
|
WO2022169615A1
(en)
|
2021-02-05 |
2022-08-11 |
Arcutis Biotherapeutics, Inc. |
Roflumilast formulations with an improved pharmacokinetic profile
|
|
WO2023057599A1
(en)
|
2021-10-07 |
2023-04-13 |
Eligo Bioscience |
Methods involving bacteroides strain replacement
|
|
WO2023057598A1
(en)
|
2021-10-07 |
2023-04-13 |
Eligo Bioscience |
Methods involving bacterial strain replacement
|
|
US12453721B2
(en)
|
2021-12-28 |
2025-10-28 |
Arcutis Biotherapeutics, Inc. |
Topical roflumilast aerosol foams
|
|
WO2024058848A1
(en)
|
2022-09-15 |
2024-03-21 |
Arcutis Biotherapeutics, Inc. |
Pharmaceutical compositions of roflumilast and solvents capable of dissolving high amounts of the drug
|